Key Capital Corporation Share Price

Stocks

Market Closed - OTC Markets 14:32:55 17/08/2026 BST			5-day change	1st Jan Change
0.000100 ^USD	-.--%		-.--%	-

05/03/20	Key Capital Corporation Seeks Partners for Development of KV-C19 Coronavirus Therapeutic Vaccine Using Proven Immunotherapy Platform	CI
13/11/19	Key Capital Corporation completed the acquisition of 20% stake in GoldVault.	CI

05/03/20	Key Capital Corporation Seeks Partners for Development of KV-C19 Coronavirus Therapeutic Vaccine Using Proven Immunotherapy Platform	CI
13/11/19	Key Capital Corporation completed the acquisition of 20% stake in GoldVault.	CI
16/05/19	Key Capital Partners Cancer Research Center to Trial Breakthrough Immunotherapy Vaccine	CI
16/05/19	Key Capital Corporation Announces Immunitor Hepcortespenlisimut-L Oral Vaccine Demonstrated Highly Promising Results in Late-Stage Liver Cancer Patients	CI
01/04/19	Key Capital Corporation agreed to acquire 20% stake in GoldVault for $2.4 million.	CI
08/11/18	SMTC Corporation acquired MC Test Service, Inc. from a group of shareholders for $70 million.	CI
30/11/17	Key Capital Corporation Enters Licensing and Development Agreement with Crypto Investor, Inc	CI
27/11/17	Key Capital Corporation Establishes Blockchain Fintech Division; Signs Gold Pre-Purchase Agreement with GoldCrypto.io to Deliver Gold Bullion	CI
13/04/17	Key Capital Corporation Announces Terminal Liver Cancer Trial Results Publication	CI
07/03/17	Key Capital Corporation Enters in to Licensing Agreement with Immunitor, Inc	CI
16/08/15	GeoGlobal Resources Inc. announced that it has received $1.2 million in funding from Key Capital Corporation	CI
12/09/14	Key Capital Corporation acquired 65% stake in GeoGlobal Resources Inc..	CI
29/08/14	Key Capital Corporation Reports Earnings Results for the First Quarter Ended June 30, 2014	CI

23/04/25	Iron Key Capital Unveils 2025 Whitepaper: "Why Seed, Why Now?" Making the Case for Early-Stage Venture Investing in Web3 and AI	AQ
10/03/20	Key Capital Coronavirus Treatment Advantage	GL
05/03/20	Key Capital : Seeks Partners for Development of KV-C19 Coronavirus Therapeutic Vaccine Using Proven Immunotherapy Platform	AQ
20/11/19	Key Capital Progresses Hospital Cancer Research and Treatment Center	GL
14/11/19	Key Capital Acquires 20% of GoldVault	GL